Modak A - Search Results

1

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study.

de With M, Knikman J, de Man FM, Lunenburg CATC, Henricks LM, van Kuilenburg ABP, Maring JG, van Staveren MC, de Vries N, Rosing H, Beijnen JH, Pluim D, Modak A, Imholz ALT, van Schaik RHN, Schellens JHM, Gelderblom H, Cats A, Guchelaar HJ, Mathijssen RHJ, Swen JJ, Meulendijks D. de With M, et al. Among authors: modak a. Clin Pharmacol Ther. 2022 Jul;112(1):62-68. doi: 10.1002/cpt.2608. Epub 2022 May 4. Clin Pharmacol Ther. 2022. PMID: 35397172 Free PMC article.

2

Breath tests to phenotype drug disposition in oncology.

Opdam FL, Modak AS, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Clin Pharmacokinet. 2013 Nov;52(11):919-26. doi: 10.1007/s40262-013-0099-9. Clin Pharmacokinet. 2013. PMID: 23868281 Review.

3

Further characterization of a ¹³C-dextromethorphan breath test for CYP2D6 phenotyping in breast cancer patients on tamoxifen therapy.

Opdam FL, Modak AS, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Among authors: modak as. J Breath Res. 2015 Apr 20;9(2):026003. doi: 10.1088/1752-7155/9/2/026003. J Breath Res. 2015. PMID: 25891764

4

Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test.

Mattison LK, Ezzeldin H, Carpenter M, Modak A, Johnson MR, Diasio RB. Mattison LK, et al. Among authors: modak a. Clin Cancer Res. 2004 Apr 15;10(8):2652-8. doi: 10.1158/1078-0432.ccr-03-0374. Clin Cancer Res. 2004. PMID: 15102667

5

The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.

Opdam FL, Dezentje VO, den Hartigh J, Modak AS, Vree R, Batman E, Smorenburg CH, Nortier JW, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Among authors: modak as. Cancer Chemother Pharmacol. 2013 Mar;71(3):593-601. doi: 10.1007/s00280-012-2034-4. Epub 2012 Dec 11. Cancer Chemother Pharmacol. 2013. PMID: 23228987

6

Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.

Mattison LK, Fourie J, Desmond RA, Modak A, Saif MW, Diasio RB. Mattison LK, et al. Among authors: modak a. Clin Cancer Res. 2006 Sep 15;12(18):5491-5. doi: 10.1158/1078-0432.CCR-06-0747. Clin Cancer Res. 2006. PMID: 17000684

7

CYP2D6 Metabolism in Frail Elderly Compared to Non-Frail Elderly: A Pilot Feasibility Study.

Opdam FL, Modak AS, Mooijaart SP, Louwerens M, de Waal MW, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Among authors: modak as. Drugs Aging. 2015 Dec;32(12):1019-27. doi: 10.1007/s40266-015-0319-0. Drugs Aging. 2015. PMID: 26597400 Free PMC article.

8

Single time point diagnostic breath tests: a review.

Modak AS. Modak AS. J Breath Res. 2010 Mar;4(1):017002. doi: 10.1088/1752-7155/4/1/017002. Epub 2009 Dec 18. J Breath Res. 2010. PMID: 21386204 Review.

9

CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine.

Klieber M, Oberacher H, Hofstaetter S, Beer B, Neururer M, Amann A, Alber H, Modak A. Klieber M, et al. Among authors: modak a. J Pharmacol Exp Ther. 2015 Sep;354(3):426-30. doi: 10.1124/jpet.115.225680. Epub 2015 Jul 9. J Pharmacol Exp Ther. 2015. PMID: 26159874

10

Evaluation of a [13C]-dextromethorphan breath test to assess CYP2D6 phenotype.

Leeder JS, Pearce RE, Gaedigk A, Modak A, Rosen DI. Leeder JS, et al. Among authors: modak a. J Clin Pharmacol. 2008 Sep;48(9):1041-51. doi: 10.1177/0091270008319709. J Clin Pharmacol. 2008. PMID: 18728242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters